EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Circulating let‐7 Predicts Hepatic Fibrogenesis of 12‐Month Post‐Nucleos(t)ide Analog Treatment in Patients With Hepatitis B Virus

Yi-Shan Tsai iD, Po-Cheng Liang, Yi-Hung Lin, Tyng-Yuan Jang, Yu-Ju Wei, Po-Han Chen, Jia-Ning Hsu, Meng-Hsuan Hsieh, Ming-Yen Hsieh, Chih-Wen Wang, Zu-Yau Lin, Ming-Lun Yeh und 5 weitere

The Kaohsiung Journal of Medical Sciences · 2025

DOI: 10.1002/kjm2.70015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, 2025. Verfasst von Yi-Shan Tsai und 16 weiteren Autor:innen. Beteiligte Einrichtung: Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Ka…. Hauptthemen laut MEDLINE: Liver Cirrhosis, Hepatitis B virus, MicroRNAs, Antiviral Agents. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Council of Taiwan, Kaohsiung Medical University Hospital, Kaohsiung Medical University Chung-Ho Memorial Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic hepatitis B virus (HBV) infection is associated with potential complications of liver cirrhosis and hepatocellular carcinoma. To date, there are no effective and noninvasive clinical markers that can predict the risk of liver fibrosis early and accurately in chronic hepatitis B (CHB) patients treated with nucleos(t)ide analogs (NAs). This study aimed to investigate the association of circulating let‐7b/c/g levels with the severity of hepatic fibrosis with a FIB‐4 index of 1.5–2.9 in CHB patients. We conducted a retrospective longitudinal study in patients with CHB after 6 months of NAs therapy to investigate whether serum let‐7b/c/g levels can be monitored as an early biomarker for liver fibrogenesis based on multivariate logistic regression analyses. We also used the hepatic stellate cell line LX‐2 treated with transforming growth factor‐β (TGF‐β) to evaluate the suppression effect of let‐7b/c/g on hepatic fibrogenesis. The study showed that circulating let‐7b/c/g could predict 12 months of antiviral treatment for HBV‐related significant fibrosis (FIB‐4 index ≥ 2.9) at baseline and was significantly negatively correlated with the FIB‐4 score. Moreover, let‐7b/c/g could directly target the TGF‐βR1–3′ untranslated region (3′ UTR) and inhibit TGF‐β induced p‐SMAD2 phosphorylation to reduce α‐smooth muscle actin levels, a fibrogenesis marker in LX‐2 cells. These results confirm that let‐7b/c/g could be a biomarker for monitoring HBV‐induced fibrogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisHepatitis B virusMicroRNAsAntiviral AgentsHepatitis B, ChronicNucleosidesHumansMaleFemaleMiddle AgedAdultRetrospective StudiesBiomarkersHepatic Stellate CellsCell LineTransforming Growth Factor betaSmad2 ProteinActins

Stichwörter der Autor:innen

TGF‐βhepatic stellate cellsliver fibrosismicroRNAsnucleos(t)ide analogs

Substanzen

mirnlet7 microRNA, humanMicroRNAsAntiviral AgentsBiomarkersTransforming Growth Factor betaSmad2 ProteinActinsNucleosidesSMAD2 protein, human

Autor:innen und Institutionen

  • Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Health Management Center & Department of Occupational Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Faculty of Internal Medicine, College of Medicine and Drug Development and Value Creation Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • School of Medicine, College of Medicine and Center of Excellence for Metabolic Associated Fatty Liver Disease, National Sun Yat-sen University, Kaohsiung, Taiwan.

ORCID-Profile: Yi-Shan Tsai

Förderung

  • National Science Council of Taiwan
  • Kaohsiung Medical University Hospital
  • Kaohsiung Medical University Chung-Ho Memorial Hospital

Zitieren

APA

Tsai, Y. S., Liang, P. C., Lin, Y. H., Jang, T. Y., Wei, Y. J., Chen, P. H., Hsu, J. N., Hsieh, M. H., Hsieh, M. Y., Wang, C. W., Lin, Z. Y., Yeh, M. L., Huang, C. F., Huang, J. F., Yu, M. L., Chuang, W. L., & Dai, C. Y. (2025). Circulating let‐7 Predicts Hepatic Fibrogenesis of 12‐Month Post‐Nucleos(t)ide Analog Treatment in Patients With Hepatitis B Virus. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.70015

Vancouver

Tsai YS, Liang PC, Lin YH, Jang TY, Wei YJ, Chen PH, et al. Circulating let‐7 Predicts Hepatic Fibrogenesis of 12‐Month Post‐Nucleos(t)ide Analog Treatment in Patients With Hepatitis B Virus. The Kaohsiung Journal of Medical Sciences. 2025. doi:10.1002/kjm2.70015

BibTeX
@article{Tsai2025,
  author = {Tsai, Yi-Shan and Liang, Po-Cheng and Lin, Yi-Hung and Jang, Tyng-Yuan and Wei, Yu-Ju and Chen, Po-Han and Hsu, Jia-Ning and Hsieh, Meng-Hsuan and Hsieh, Ming-Yen and Wang, Chih-Wen and Lin, Zu-Yau and Yeh, Ming-Lun and Huang, Chung-Feng and Huang, Jee-Fu and Yu, Ming-Lung and Chuang, Wan-Long and Dai, Chia-Yen},
  title = {Circulating let‐7 Predicts Hepatic Fibrogenesis of 12‐Month Post‐Nucleos(t)ide Analog Treatment in Patients With Hepatitis B Virus},
  journal = {The Kaohsiung Journal of Medical Sciences},
  year = {2025},
  doi = {10.1002/kjm2.70015}
}
Kostenlos starten →